clinical research involving humans revealed that hydroxychloroquine was ineffective.Virologists at the Rega Institute for Medical Research in Leuven, Belgium, have now developed a model of COVID-19 in Syrian hamsters, which they hope will provide more reliable information before the results of clinical trials become available.They have already used their animal model to test different doses of favipiravir, an antiviral drug that has had approval in Japan since 2014 to treat pandemic influenza infections.
Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.The researchers found that while low doses of the drug gave poor results against SARS-CoV-2, high.